Company intelligence / Profile preview
InBio
Charlottesville, Virginia, United Statesinbio.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
InBio offers an extensive portfolio of validated diagnostic products (including multiparameter allergen assays and purified allergen proteins) widely adopted in clinical and research settings, with prominent scientific leadership in allergen characterization and environmental measurement technology. The company is pioneering CRISPR-based gene editing for cat allergy and new mass spectrometry-based allergen detection for food.
- Therapeutic areas
- ImmunologyPulmonology
- Modalities
- BiologicMonoclonal antibodyRecombinant proteinPurified natural protein
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Collaborations with academic institutionsallergy diagnostics manufacturersglobal distributors including European regulatory agencies for assay validation
Beyond the preview
Go deeper on InBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InBio.